SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-007335
Filing Date
2020-03-25
Accepted
2020-03-25 14:28:20
Documents
4
Period of Report
2020-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119961-8k_aikidopharma.htm 8-K 40640
2 CERTIFICATE OF DESIGNATION OF SERIES L PREFERRED STOCK OF AIKIDO PHARMA INC. ea119961ex3-1_aikido.htm EX-3.1 35903
3 RIGHTS AGREEMENT, DATED AS OF MARCH 23, 2020, BY AND BETWEEN AIKIDO PHARMA INC., ea119961ex4-1_aikido.htm EX-4.1 369470
4 PRESS RELEASE OF AIKIDO PHARMA INC., DATED MARCH 23, 2020 ea119961ex99-1_aikido.htm EX-99.1 10727
  Complete submission text file 0001213900-20-007335.txt   458360
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 20741711
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services